Previous close | 2.0000 |
Open | 2.7500 |
Bid | 0.8000 |
Ask | 4.3000 |
Strike | 110.00 |
Expiry date | 2024-06-21 |
Day's range | 2.7500 - 2.7500 |
Contract range | N/A |
Volume | |
Open interest | 40 |
AUSTIN, Texas, June 03, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 7:40 a.m. PT (10:40 a.m. ET).
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. US markets performed strongly in Q1, with the S&P Index up 10.56%. Investor confidence rose with the anticipated soft landing of the market. However, Class A shares […]
On May 30, 2024, Gail Marcus, Director at Natera Inc (NASDAQ:NTRA), executed a sale of 2,000 shares of the company at a price of $110.17 per share.